? ? Our Training Program in Pulmonary Disease provides comprehensive research training for individuals with a serious commitment to a career in lung biology and biomedical research, particularly as it interfaces with clinical pulmonary medicine. Our primary premise has long been that lung diseases represent major health problems in the U.S. and that progress toward improved understanding of the pathobiology of these diseases are required to make progress toward treatment and prevention. The program has a long history, training numerous physicians and scientists who have subscribed to this mission. The program is under new leadership and strives to maintain the previous scientific and training success, while adapting the next generation of researchers to new basic and clinical science knowledge and technology. Recent changes have included expanded resources (space and faculty - including 6 Ph.D. scientists). This has allowed us to broaden the scope of research questions related to lung biology, and attack the problems at the most basic and translational levels incorporating new cores in the Lung Biology Center and Harvard Medical Center. We have also enhanced our didactic program and further solidified program organization for oversight and mentoring of trainees. We identify trainees with a demonstrated interest in a research career. We also identify an environment where these individuals can pursue a problem of interest and in which creative and solid thinking combined with state-of-the-art technology is being used to pursue the problem, and provide them with the tools and mind-set to attack other problems in the future. Finally, we provide a prolonged period of support (3-5 years) so that trainees are prepared ultimately to become a productive independent investigator, and the next leaders in pulmonary academics. This has resulted in our 46 trainees publishing 332 manuscripts over the past decade, and of the 37 trainees who have completed the program, 33 have obtained grant awards. Importantly, 62% of our trainees spend over 50% if their time doing research, and only one trainee (3%) in the past decade is now in private practice. (END OF ABSTRACT) ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007633-23
Application #
7283715
Study Section
Special Emphasis Panel (ZHL1-CSR-G (F1))
Program Officer
Rothgeb, Ann E
Project Start
1985-07-01
Project End
2010-07-31
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
23
Fiscal Year
2007
Total Cost
$542,311
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
González, Germán; Ash, Samuel Y; San José Estépar, Raúl et al. (2018) Reply to Mummadi et al.: Overfitting and Use of Mismatched Cohorts in Deep Learning Models: Preventable Design Limitations. Am J Respir Crit Care Med 198:545
Ash, Samuel Y; Harmouche, Rola; Ross, James C et al. (2018) Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort. Radiology 288:600-609
Courtwright, Andrew M; Zaleski, Derek; Gardo, Lisa et al. (2018) Causes, Preventability, and Cost of Unplanned Rehospitalizations Within 30 Days of Discharge After Lung Transplantation. Transplantation 102:838-844
Taglauer, Elizabeth; Abman, Steven H; Keller, Roberta L (2018) Recent advances in antenatal factors predisposing to bronchopulmonary dysplasia. Semin Perinatol 42:413-424
Cao, Severine; Courtwright, Andrew M; Lamattina, Anthony M et al. (2018) The impact of screening method on HLA antibody detection before and after lung transplantation: A prospective pilot study. J Heart Lung Transplant 37:531-533
Ash, Samuel Y; Rahaghi, Farbod N; Come, Carolyn E et al. (2018) Pruning of the Pulmonary Vasculature in Asthma. The Severe Asthma Research Program (SARP) Cohort. Am J Respir Crit Care Med 198:39-50
Kalhan, Ravi; Dransfield, Mark T; Colangelo, Laura A et al. (2018) Respiratory Symptoms in Young Adults and Future Lung Disease. The CARDIA Lung Study. Am J Respir Crit Care Med 197:1616-1624
González, Germán; Ash, Samuel Y; Vegas-Sánchez-Ferrero, Gonzalo et al. (2018) Disease Staging and Prognosis in Smokers Using Deep Learning in Chest Computed Tomography. Am J Respir Crit Care Med 197:193-203
Miller, Ezra R; Putman, Rachel K; Vivero, Marina et al. (2018) Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections. Am J Respir Crit Care Med 197:955-958
Baron, Rebecca M; Kwon, Min-Young; Castano, Ana P et al. (2018) Frontline Science: Targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsis. J Leukoc Biol 104:677-689

Showing the most recent 10 out of 190 publications